Zucara Therapeutics
Zucara Therapeutics is a diabetes life sciences company developing ZT-01, a first-in-class, once-daily therapeutic designed to prevent hypoglycemia in people with type 1 and insulin-dependent type 2 diabetes. ZT-01 works by inhibiting somatostatin, restoring glucagon secretion to prevent low blood glucose levels, improving patient health and quality of life. The company aims to revolutionize diabetes management.
Funding Round: Series B
Funding Amount: $20M
Date: 12-Nov-2024
Investors: Sanofi, Perceptive Advisors' PXV Fund I
Markets: Life Sciences, Diabetes Therapeutics, Drug Discovery, Biotechnology
HQ: Toronto, Ontario, Canada
Founded: 2015
Website: https://www.zucara.ca/
LinkedIn: https://ca.linkedin.com/company/zucara-therapeutics-inc-
Twitter: https://twitter.com/zucara_ca
Leave a Comment
Comments
No comments yet.